Latest Akira Science News & Updates

See the latest news and media coverage for Akira. We track all announcements, press releases, and industry mentions in real time, all in one place.

Akira Science (Akira)

Developer of bioresorbable biomaterials for soft tissue repair

Last updated Today

Latest news about Akira Science (Akira)

In short: Akira advanced its AkiMed bioresorbable polymer platform for breast reconstruction and aesthetic medicine while securing key funding.

May 20 Akira

The AkiMed scaffold is bioresorbable, placed during lumpectomy to support natural tissue regeneration.

May 8 Akira

The funding supports external expertise to build the company. Medtech4Health is a Vinnova-funded program accelerating medtech innovations.

March 31 Akira

Q1 2026 milestones include EU/UK patents granted, US filing, and €0.5M EIC Pathfinder award. The company evolves into a commercial MedTech firm.

January 22 Akira

She brings 15+ years in MedTech and healthtech, focusing on regulatory foundations, quality, and commercialization of their biomaterial platform.

31 March 2025 3Dnatives

We spoke to Akira Science about their work in 3D printing biomaterials for tissue regeneration to help in treatment for diseases like cancer.

Never miss news about Akira

Track Akira and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Browse news for competitors to Akira and other trending companies.